Michel Feldman has over 40 years of experience in complex corporate transactions and concentrates his practice on the representation of numerous individuals, families, trusts, and public and private corporations across a wide range of industries including pharmaceuticals, medical devices, computer software, entertainment, manufacturing, distribution, and retail.  Mr. Feldman is a frequent lecturer and author on mergers and acquisitions, capital raising and corporate governance issues.

Among his accomplishments, Mr. Feldman has counseled a NYSE pharmaceutical company regarding start-up financing, venture capital, two public offerings, various mergers with public and private companies, and licensing, distribution and acquisition agreements with domestic and foreign companies, and served as its interim General Counsel for nine months.

He has also structured and assisted with the planning, negotiation and financing of transactions involving management buy outs and merger and acquisitions ranging from $1 million to $1 billion, including Special Purpose Acquisition (SPAC) transactions.

Michel Feldman has over 40 years of experience in complex corporate transactions and concentrates his practice on the representation of numerous individuals, families, trusts, and public and private corporations across a wide range of industries including pharmaceuticals, medical devices, computer software, entertainment, manufacturing, distribution, and retail.  Mr. Feldman is a frequent lecturer and author on mergers and acquisitions, capital raising and corporate governance issues.

Among his accomplishments, Mr. Feldman has counseled a NYSE pharmaceutical company regarding start-up financing, venture capital, two public offerings, various mergers with public and private companies, and licensing, distribution and acquisition agreements with domestic and foreign companies, and served as its interim General Counsel for nine months.

He has also structured and assisted with the planning, negotiation and financing of transactions involving management buy outs and merger and acquisitions ranging from $1 million to $1 billion, including Special Purpose Acquisition (SPAC) transactions.